EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/407647
EW NEWS & OPINION 8 November 2014 © 2013 Novartis 9/13 RES13076JAD CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician. INDICATIONS: The AcrySof ® IQ ReSTOR ® Posterior Chamber Intraocular Lens (IOL) is intended for primary implantation for the visual correction of aphakia second- ary to removal of a cataractous lens in adult patients with and without presby- opia, who desire near, intermediate and distance vision with increased spectacle independence. The lens is intended to be placed in the capsular bag. WARNING/PRECAUTION: Careful pre- operative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before im- planting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia, and ensure that IOL centra- tion is achieved. Care should be taken to remove viscoelastic from the eye at the close of surgery. Some patients may experience visual dis- turbances and/or discomfort due to mul- tifocality, especially under dim light con- ditions. Clinical studies with the AcrySof ® ReSTOR ® lens indicated that posterior capsule opacification (PCO), when pres- ent, developed earlier into clinically sig- nificant PCO. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Bro- chure available from Alcon for this prod- uct informing them of possible risks and benefits associated with the AcrySof ® IQ ReSTOR ® IOLs. Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof ® Natural IOL and normal color vision. The effect on vision of the AcrySof ® Natural IOL in subjects with hereditary color vision de- fects and acquired color vision defects secondary to ocular disease (e.g., glauco- ma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS ® or BSS PLUS ® Sterile Intraocular Irrigating Solu- tions. ATTENTION: Reference the Directions for Use labeling for a complete listing of indi- cations, warnings and precautions. www.AcrySofReSTOR.com Supplement inside this issue highlights relevant clinical trends in ophthalmology A SCRS has completed its second annual Clinical Survey and published some of the most exciting results in a supplement included with this issue. The 2014 survey, developed by ASCRS Clinical Committees, included 134 questions. These were designed to measure the clinical opinions and practice patterns among ASCRS members, looking at the compelling issues facing ophthalmologists today. "The survey establishes a clinical norm or guide upon which ASCRS members can compare their own surgical outcomes," said ASCRS President Richard Lewis, MD, a glaucoma specialist in private practice, Sacramento, Calif. About the survey More than 1,500 physicians completed the survey at the 2014 ASCRS•ASOA Symposium & Congress in Boston and via electronic follow-up after the meeting, representing a significant portion of the ASCRS membership. "Many of these survey questions can be a benchmark for what the state of the practice is, whether we're talking about cataract surgery, glaucoma surgery, corneal surgery, or management of medical problems," said ASCRS Program Committee Chair Edward Holland, MD, director of cornea services, Cincinnati Eye Institute, and professor of ophthalmology, University of Cincinnati. "A lot of this information has never been acquired before, so I think it's a very novel approach," he said. "It will allow our members to benchmark themselves with their peers." In addition to determining members' opinions on key issues, the survey identified educational gaps in physicians' education. The ASCRS Clinical Committees are using those results to develop educational objectives for future ASCRS programs. "This data will help us redefine where we want to go with our education," Dr. Holland said. "It will help us identify gaps in our education and redirect our teaching to address those gaps." The supplement The supplement inside this issue of EyeWorld provides an overview of survey results, including responses on the topics of Results from second annual ASCRS Clinical Survey published by Lauren Lipuma EyeWorld Staff Writer presbyopia correction, astigmatism management, ocular surface disease, and laser-assisted cataract surgery. The supplement also includes results from questions posed specifically to young ophthalmologists—residents, fellows, or those with less than 5 years of practice. In addition to this supplement, future issues of EyeWorld and the Journal of Cataract & Refractive Surgery will feature articles highlighting the survey's results and analyses of the key trends and gaps it identifies. By helping to define practice patterns, the survey results will have a big impact on the practice of ophthalmology, Dr. Holland said. "Leaders in each of the fields have an idea of where they think clinicians should be in terms of education, and sometimes they're surprised that clinicians aren't where they thought they were," he said. "[The survey] will change their thinking and change the way they teach." "The survey is unique in providing members an annual comparison tool to achieve ongoing career education," Dr. Lewis said. "This tool will help raise the bar for all of ophthalmology in maximizing outcomes." EW Editors' note: Drs. Holland and Lewis have no financial interests related to their comments. Contact information Holland: eholland@holprovision.com Lewis: rlewiseyemd@yahoo.com 35% of subjects who had no halos prior to surgery developed new halos at 3 months. This was a subset of 31 patients out of the 260 patients examined at 3 months. The instances where preoperative symptoms (such as halos) disappeared following surgery were not presented. › 28% of subjects who had a normal preop OSDI noted mild, moderate, or severe dry eye at 3 months. The percent of patients who had mild, moderate, or severe dry eye preoperatively, who had a normal OSDI postop- eratively was not presented. › The majority of the dissatis- fied patients reported visual symptoms, such as glare, halos, ghosting or starbursts. The number of patients for whom refractive correction would have eliminated these symptoms was not presented. Subjects were not followed long enough to evaluate the resolution of dry eye symptoms that typically occur after LASIK. Nor were they followed long enough to evaluate the long-term effects of LASIK. EW Contact information Cindy Sebrell: csebrell@ASCRS.org ASCRS responds continued from page 3